英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
ExemestaneRelatedCompound3 |
雷芬那辛雜質(zhì)8 |
108015-71-0 |
詳細(xì)
|
Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]-, methyl ester |
雷芬那辛雜質(zhì)64 |
733783-20-5 |
詳細(xì)
|
Unii-L742P1D49E |
雷芬那辛雜質(zhì)53 |
108335-90-6 |
詳細(xì)
|
Ethanamine,2,2-dimethoxy-N,N-dimethyl- |
雷芬那辛雜質(zhì)67 |
50663-73-5 |
詳細(xì)
|
ExemestaneRelatedCompoundB |
雷芬那辛雜質(zhì)37 |
864750-95-8 |
詳細(xì)
|
Methyleneboldenone |
雷芬那辛雜質(zhì)11 |
1289178-26-2 |
詳細(xì)
|
Exemestane |
雷芬那辛雜質(zhì)25 |
1158699-78-5 |
詳細(xì)
|
ExemestaneImpurity13 |
雷芬那辛雜質(zhì)16 |
14882-18-9 |
詳細(xì)
|
Androsta-1,4-diene-3,17-dione,4-chloro-6-methylene- |
雷芬那辛雜質(zhì)15 |
38711-20-5 |
詳細(xì)
|
3-(CYANOMETHYL)BENZOIC ACID |
酮基布洛芬雜質(zhì)8(酮基布洛芬EP雜質(zhì)H) |
5689-33-8 |
詳細(xì)
|
5-O-Phosphono-beta-D-Ribofuranose |
酮基布洛芬雜質(zhì)31 |
59960-32-6 |
詳細(xì)
|
Meester-(E)-Clavulanicacid,BAN,INN |
艾沙康唑雜質(zhì)17 單體 |
2832083-17-5 |
詳細(xì)
|
3-Methyl-4-nitroquinoline1-oxide |
1,5-萘啶 N-氧化物 |
27305-48-2 |
詳細(xì)
|
4-Methoxy-5,6,7,8-tetrahydroquinoline1-oxide |
2-氯喹啉-N-氧化物 |
2423-68-9 |
詳細(xì)
|
(αR,βS)-rel-Bedaquiline |
isoquinoline 1-carboxylic acid N-oxide |
22960-55-0 |
詳細(xì)
|
4-Amino-2-methylnaphthalen-1-olhydrochloride |
4-溴喹啉氮氧化物 |
22614-98-8 |
詳細(xì)
|
2-MethylquinolineN-oxide |
8-甲氧基喹啉氮氧化物 |
22614-90-0 |
詳細(xì)
|
Cefazolin Impurity 2(Cefazolin EP Impurity B)(Cefazolin USP RC N) |
頭孢唑啉雜質(zhì)2(頭孢唑啉EP雜質(zhì)B)(頭孢唑啉USP RC N) |
2384108-14-7 |
詳細(xì)
|
Quinoline,2-methoxy-,1-oxide |
5-羥基喹啉氮氧化物 |
188530-04-3 |
詳細(xì)
|
Benzene,1,4-dichloro-2-(trichloromethyl)- |
酮基布洛芬雜質(zhì)7(酮基布洛芬EP雜質(zhì)G) |
5537-71-3 |
詳細(xì)
|
(1-hydroxy-5-nitro-8-oxo-8,8a-dihydroquinolinium) |
1-oxy-5,6,7,8-tetrahydro-quinolin-8-ol |
39585-74-5 |
詳細(xì)
|
Stavudine Impurity 11 |
丙胺卡因 |
620-71-3 |
詳細(xì)
|
(1R,2R)-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol |
8-甲基-4-硝基喹啉氮氧化物 |
14094-45-2 |
詳細(xì)
|
Zaltoprofen |
雷沙吉蘭雜質(zhì)6 |
138911-07-6 |
詳細(xì)
|
Valerophenone |
雷沙吉蘭雜質(zhì)17 |
1458609-07-8 |
詳細(xì)
|
Esomeprazole Impurity 58 |
埃索美拉唑雜質(zhì)58 |
1424857-95-3 |
詳細(xì)
|
2H-Pyran,3,4-dihydro-6-methyl- |
2-氰基-N-[(甲基氨基)羰基]乙酰胺 |
6972-77-6 |
詳細(xì)
|
Minocycline Impurity 7(Minocycline Dehydro Impurity) |
米諾環(huán)素雜質(zhì)7(米諾環(huán)素脫羥基雜質(zhì)) |
19119-14-3 |
詳細(xì)
|
(1S,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol |
3-甲基-4-硝基喹啉N-氧化物 |
14073-00-8 |
詳細(xì)
|
2,3-dihydro-N1-2-propyn-1-yl-1H-Indene-1,6-diamine |
雷沙吉蘭雜質(zhì)33 |
863987-58-0 |
詳細(xì)
|
Malibavir impurity 26 |
馬立巴韋雜質(zhì)26 |
1407485-69-1 |
詳細(xì)
|
Malibavir impurity 27 |
馬立巴韋雜質(zhì)27 |
1407485-68-0 |
詳細(xì)
|
AmlodipineImpurity31 |
氨氯地平雜質(zhì)29 |
93848-82-9 |
詳細(xì)
|
INDEX NAME NOT YET ASSIGNED |
舒更葡糖雜質(zhì)22(Org197339-1) |
2379877-91-3 |
詳細(xì)
|
org246653-1 |
舒更葡糖雜質(zhì)36(Org246653-1(RRT0.35)) |
2412953-09-2 |
詳細(xì)
|
(S)-(+)-Ibuprofen |
舒更葡糖雜質(zhì)25 鈉鹽 |
2412952-92-0 |
詳細(xì)
|
1,5-Naphthyridine,1,5-dioxide |
2-甲基-4-硝基喹啉氮氧化物 |
4831-62-3 |
詳細(xì)
|
Heptanal,3-hydroxy-2-propyl- |
扎托布洛芬 |
74711-43-6 |
詳細(xì)
|
Benzenesulfonicacid,4-methyl-,(2R)-2-ethylhexylester |
布洛芬雜質(zhì)35 |
1009-14-9 |
詳細(xì)
|
AmphoteronolideB |
酮基布洛芬雜質(zhì)39 |
1272414-15-9 |
詳細(xì)
|
Methyl2,3-O-isopropylidene-beta-D-ribofuranoside |
布洛芬雜質(zhì)74 |
103931-20-0 |
詳細(xì)
|
1,5-Naphthyridine,1-oxide |
4-氯喹啉-N-氧化物 |
4637-59-6 |
詳細(xì)
|
Quinoline,4-methoxy-,1-oxide |
4-羥基喹啉氮氧化物 |
3039-74-5 |
詳細(xì)
|
Quinoline,8-methyl-4-nitro-,1-oxide |
貝達(dá)喹啉雜質(zhì)57 |
27305-49-3 |
詳細(xì)
|
VonoprazanImpurity1 |
2-氯-5-苯基-1H-吡咯-3-甲腈 |
158692-52-5 |
詳細(xì)
|
Bedaquiline |
4-甲氧基-5,6,7,8-四氫喹啉氮氧化物 |
125162-99-4 |
詳細(xì)
|
(2R)-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol |
4-甲氧基喹啉氮氧化物 |
14547-98-9 |
詳細(xì)
|
Bedaquiline(MixtureofDiastereomers) |
3-甲基異喹啉氮氧化物 |
14548-00-6 |
詳細(xì)
|
7-Oxyisotithocholic Acid |
熊去氧膽酸雜質(zhì)L |
67008-26-8 |
詳細(xì)
|
Malibavir impurity 28 |
馬立巴韋雜質(zhì)28 |
193527-29-6 |
詳細(xì)
|
Cycloserine impurity 63 |
環(huán)絲氨酸雜質(zhì)63 |
39251-40-6 |
詳細(xì)
|
Lactic Acid Impurity 52 |
阿莫西林 |
26787-78-0 |
詳細(xì)
|
isoquinoline1-carboxylicacidN-oxide |
2-methyl-4-methoxy-quinoline-1-oxide |
41037-31-4 |
詳細(xì)
|
Potassium glycyrrhizinate |
甘草酸二鉀鹽 |
68797-35-3 |
詳細(xì)
|
Quinoline,4-bromo-,1-oxide |
6-甲基喹啉氮氧化物 |
4053-42-3 |
詳細(xì)
|
Isoquinoline,5-bromo-,2-oxide |
8-METHYLQUINOLINE N-OXIDE |
4053-38-7 |
詳細(xì)
|
Quinoline,8-methoxy-,1-oxide |
4-甲基喹啉-N-氧化物 |
4053-40-1 |
詳細(xì)
|
Methanone,(3-chloro-1H-indol-7-yl)phenyl- |
扎托布洛芬雜質(zhì)3(扎洛芬硫氧化物) |
134085-79-3 |
詳細(xì)
|
1-(Phenylcarbamoyl)cyclopropanecarboxylicacid |
布洛芬雜質(zhì)45 |
83394-44-9 |
詳細(xì)
|
Sugammadex Impurity 4 |
舒更葡糖雜質(zhì)4 |
343306-71-8 |
詳細(xì)
|
KetoprofenTromethamineAmide |
雷沙吉蘭雜質(zhì)11 |
1312077-05-6 |
詳細(xì)
|
Benzeneaceticacid,3-benzoyl-a-methyl-,ethylester |
雷沙吉蘭雜質(zhì)5 |
10277-74-4 |
詳細(xì)
|
Azetidine,1-(6-ethynyl-2,3-dihydro-1H-inden-1-yl)-(9CI) |
雷沙吉蘭雜質(zhì)32 |
371251-20-6 |
詳細(xì)
|
Sugammadex Impurity 22 |
舒更葡糖雜質(zhì)58(Org238832-1(RRT1.72)) |
2412952-94-2 |
詳細(xì)
|
(R)-(-)-Ketoprofen |
磺胺多辛雜質(zhì)6 |
5018-23-5 |
詳細(xì)
|
rac-2’,4’-DimethylKetoprofen |
磺胺多辛雜質(zhì)1 磺胺多辛 (N4-乙?;? |
5018-54-2 |
詳細(xì)
|
rac-2’,4’,5’-TrimethylKetoprofen |
磺胺多辛雜質(zhì)4 (磺胺多辛4 O-二甲基) |
1346604-08-7 |
詳細(xì)
|
Dexketoprofen |
磺胺多辛雜質(zhì)5 |
5018-45-1 |
詳細(xì)
|
1,1′,3,3′-Tetrahydro[2,2′-bi-2H-indene]-2,2′-diol |
雷沙吉蘭雜質(zhì)29 |
93877-16-8 |
詳細(xì)
|
Isoquinoline,3-methyl-,2-oxide |
2-羧基喹啉氮氧化物 |
3297-64-1 |
詳細(xì)
|
3-MethylquinolineN-oxide |
2-羥甲基-4-甲氧基喹啉 |
361576-36-5 |
詳細(xì)
|
8-Quinolinol,5-chloro-,1-oxide |
2-hydroxymethylquinoline-N-oxide |
39585-73-4 |
詳細(xì)
|
Ripretinib Impurity 41 |
坦索羅辛雜質(zhì)5 |
1027854-97-2 |
詳細(xì)
|
Quinoline,4-ethoxy-6-methyl-,1-oxide |
5-溴異喹啉氮氧化物 |
223671-17-8 |
詳細(xì)
|
Ritlecitinib Impurity 37 |
利特昔替尼雜質(zhì)37 |
2411407-12-8 |
詳細(xì)
|
Ritlecitinib Impurity 53 |
利特昔替尼雜質(zhì)53 |
2914873-69-9 |
詳細(xì)
|
Ritlecitinib Impurity 58 |
利特昔替尼雜質(zhì)58 |
2411407-67-3 |
詳細(xì)
|
Sarolaner Impurity 15 |
|
1398609-48-7 |
詳細(xì)
|
Sarolaner Impurity 32 |
|
1575834-68-2 |
詳細(xì)
|
Sarolaner Impurity 37 |
|
2654696-62-3 |
詳細(xì)
|
Fedratinib Impurity 4 |
菲卓替尼雜質(zhì)4 |
1802659-73-9 |
詳細(xì)
|
Sarolaner Impurity 27 |
|
1398609-46-5 |
詳細(xì)
|
Sarolaner Impurity 43 |
|
1575794-68-1 |
詳細(xì)
|
Sarolaner Impurity 48 |
|
1575836-01-9 |
詳細(xì)
|
Ritlecitinib Impurity 41 |
利特昔替尼雜質(zhì)41 |
2411407-22-0 |
詳細(xì)
|
Ritlecitinib Impurity 61 |
利特昔替尼雜質(zhì)61 |
2411407-44-6 |
詳細(xì)
|
Sarolaner Impurity 24 |
|
1398609-89-6 |
詳細(xì)
|
Sarolaner Impurity 45 |
|
1575831-16-1 |
詳細(xì)
|
Ritlecitinib Impurity 32 |
利特昔替尼雜質(zhì)32 |
2411407-18-4 |
詳細(xì)
|
Sarolaner Impurity 40 |
|
1398609-35-2 |
詳細(xì)
|
Sarolaner Impurity 18 |
|
1575830-89-5 |
詳細(xì)
|
Fedratinib Impurity 6 |
菲卓替尼雜質(zhì)6 |
1332719-50-2 |
詳細(xì)
|
Ritlecitinib Impurity 46 |
利特昔替尼雜質(zhì)46 |
2411406-93-2 |
詳細(xì)
|
Sarolaner Impurity 21 |
|
1575794-64-7 |
詳細(xì)
|
Ritlecitinib Impurity 44 |
利特昔替尼雜質(zhì)44 |
2411407-58-2 |
詳細(xì)
|
Ritlecitinib Impurity 49 |
利特昔替尼雜質(zhì)49 |
2411407-65-1 |
詳細(xì)
|
Sarolaner Impurity 10 |
|
1398609-40-9 |
詳細(xì)
|
Methyl(2R,3E,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate |
艾沙康唑雜質(zhì)96 |
192225-36-8 |
詳細(xì)
|
amphotericinA |
酮基布洛芬雜質(zhì)32 |
2733641-85-3 |
詳細(xì)
|
Quinoline,2-chloro-,1-oxide |
2-甲基-4-氯喹啉氮氧化物 |
41037-32-5 |
詳細(xì)
|